LYKA LABS
|
The Current P/E Ratio of LYKA LABS is 177.82.
Share Price | ₹155.8 | Jan 14,2025 |
Market Cap | ₹556.0 Cr | |
Earnings-TTM | ₹3.1 Cr | TTM-Consolidated Results |
Price/Earnings | 177.82x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LYKA LABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹556.0 Cr] as on Jan 14,2025
(/) Earnings [ ₹3.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 177.82x ]
Thus, for LYKA LABS , the investors are currently willing to pay 177.82 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LYKA LABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LYKA LABS over the last five years.
Historical PE (Price/Earnings) ratio chart of LYKA LABS
PE Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.00x.
- LYKA LABS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2022 at 9.98x.
- LYKA LABS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does LYKA LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LYKA LABS | 3.13 | 177.82 | 556.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.11 | 424,382.0 |
CIPLA LTD | 4,485.22 | 26.07 | 116,943.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.64 | 111,588.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 23.43 | 100,704.0 |
DIVIS LABORATORIES LTD | 1,836.00 | 86.72 | 159,224.0 |
MANKIND PHARMA LTD | 2,124.86 | 51.87 | 110,215.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 61.12 | 110,142.0 |
LUPIN LTD | 2,651.94 | 37.08 | 98,330.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.96 | 68,238.4 |
ABBOTT INDIA LTD | 1,284.66 | 46.74 | 60,041.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LYKA LABS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.96x |
Max industry PE | 177.82x |
Median industry PE | 38.11x |
Average industry PE | 53.51x |
You may also like the below Video Courses